NCT04018430 (HbA1c) is a clinical trial in Blood Glucose, High, sponsored by Urs E. Nydegger.

Who is sponsoring NCT04018430?

NCT04018430 is sponsored by Urs E. Nydegger.

What condition does NCT04018430 study?

NCT04018430 studies Blood Glucose, High, Oral Hypoglycaemic Overdose.

Is NCT04018430 still recruiting?

NCT04018430 is currently status unknown. Last updated 12 July 2019.

Last reviewed 2019-07-12 · How we verify

NCT04018430: HbA1c

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Oral Glucose Tolerance Test on Extent of Hemoglobin Glycation

Status unknown Last updated 12 July 2019

What this trial tests

trial in Blood Glucose, High in 100 participants. Status unknown.

Timeline

1 September 2019

Primary endpoint
30 September 2020

30 September 2021

Quick facts

Lead sponsor	Urs E. Nydegger
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 September 2019
Primary completion	30 September 2020
Estimated completion	30 September 2021
Sites	1 location across Switzerland

Conditions studied

Blood Glucose, High — all drugs for Blood Glucose, High →
Oral Hypoglycaemic Overdose — all drugs for Oral Hypoglycaemic Overdose →

Sponsor

Urs E. Nydegger

Who can join

Adults 5 to 40, any sex, with Blood Glucose, High or Oral Hypoglycaemic Overdose. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The glycation extent of human hemoglobin is under control of the Maillard reaction, a chemical interaction between an amino acide and a reducing sugar. About 5% ( 31.1 mmol/mol) of hemoglobin molecules secluded in a red blood cell are glycated; excessive values \> 6.5% point to prediabetes or overt diabetes mellitus. To ascertain the diagnosis doctors prescribe oral glucose tolerance upon which glucose concentrations in blood increase - how much HbA1c reacts under these circumstances is ill known.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04018430 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Urs E. Nydegger
Last refreshed: 12 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04018430.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing